Zacks Small Cap Research on MSN14 分钟
AEMD: Oncology Trial Moves Forward as Patient Enrollments Begin, Positive on Cost ...
AEMD READ THE FULL AEMD RESEARCH REPORT Patient enrollments begin for AEMD’s basket oncology trial Aethlon Medical (NASDAQ:AEMD) announced FY 2Q results and provided a business update yesterday. The ...
Rep. Himes: ‘Truth and analysis are not what drive’ Gabbard and Gaetz
Congressman Jim Himes (D-CT), ranking member of the Intelligence Committee, joins Andrea Mitchell to discuss President-elect ...
NSW housing approvals lag behind rest of country, with high building costs and loan ...
Despite the government's commitment to deliver 377,000 new homes within five years from July, the number of new housing ...